Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,376,253
+$403,818 QoQ
Shares Held
13,417
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.91%
of 13F equity value
Holder Rank
#1,566
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL SINKLER & STARR/PA holds $19,003,477 across 8 Drug Manufacturers - General names. ABBV ranks #3 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
42,391 | $5,447,243 | |
| 2 | JNJ |
Johnson & Johnson
|
21,432 | $5,443,085 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
13,417 | $3,376,253 | |
| 4 | LLY |
ELI LILLY & Co
|
1,998 | $2,396,461 | |
| 5 | AMGN |
Amgen Inc
|
2,295 | $831,065 | |
| 6 | PFE |
Pfizer Inc
|
27,742 | $668,027 | |
| 7 | NVS |
Novartis AG
|
3,193 | $500,406 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,917 | $340,937 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,376,253 | 13,417 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,972,435 | 13,667 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $3,136,482 | 13,727 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,125,095 | 13,497 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,505,313 | 13,497 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,839,415 | 13,552 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,662,656 | 14,984 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,558,864 | 28,149 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,831,242 | 22,337 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $3,936,455 | 21,617 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $9,580,555 | 61,822 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,769,920 | 32,000 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,336,184 | 24,762 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $4,037,957 | 25,337 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,984,936 | 18,470 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,399,674 | 17,880 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,840,352 | 18,545 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,986,066 | 18,420 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,316,694 | 17,110 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,813,834 | 16,815 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,902,489 | 16,890 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,827,835 | 16,890 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,829,050 | 17,070 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,495,161 | 17,070 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $1,640,096 | 16,705 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,432,752 | 18,805 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||